BNS vs Sterile Private Label Supply Models
OEM economics often hinge on whether you sterilize in-house or buy sterile finished goods. Both paths are valid — but they imply different quality agreements and capital plans.
Bulk non-sterile advantages
BNS guidewires and sheaths let you kit and sterilize once at the finished goods level. You control sterilization validation and batch records — useful if your differentiation is kit configuration.
Private-label sterile advantages
Buying sterile singles shifts sterilization validation to the device manufacturer, accelerating market entry when you lack in-house gamma or EO capacity.
Labeling and UDI ownership
Private label means you own label content and UDI-DI allocation. BNS components may ship with manufacturer labels you must obscure or replace — clarify label artwork rights in contracts.
Change control notifications
Sterile release processes should trigger change notification for coil suppliers, packaging materials, or sterilization cycles. Write response timelines into supplier quality agreements.
Mixed models
Some distributors stock BNS for OEM kitting while hospitals buy sterile singles under a different brand. Segment ERP items to prevent cross-shipment.
American Medical Supply supports both supply models across guidewire and introducer families — state your path early in RFQ discussions.